- Home
- PHVS vs BHLB Comparison
PHVS vs BHLB Comparison
Compare PHVS & BHLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- BHLB
- Stock Information
- Founded
- PHVS 2015
- BHLB 1846
- Country
- PHVS Switzerland
- BHLB United States
- Employees
- PHVS N/A
- BHLB N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- BHLB Banks
- Sector
- PHVS Health Care
- BHLB Finance
- Exchange
- PHVS Nasdaq
- BHLB Nasdaq
- Market Cap
- PHVS 980.9M
- BHLB 1.1B
- IPO Year
- PHVS 2021
- BHLB 2000
- Fundamental
- Price
- PHVS $22.32
- BHLB $26.32
- Analyst Decision
- PHVS Buy
- BHLB Hold
- Analyst Count
- PHVS 6
- BHLB 5
- Target Price
- PHVS $37.17
- BHLB $32.70
- AVG Volume (30 Days)
- PHVS 33.8K
- BHLB 519.5K
- Earning Date
- PHVS 08-13-2025
- BHLB 07-24-2025
- Dividend Yield
- PHVS N/A
- BHLB 2.71%
- EPS Growth
- PHVS N/A
- BHLB 392.17
- EPS
- PHVS N/A
- BHLB 2.46
- Revenue
- PHVS N/A
- BHLB $431,403,000.00
- Revenue This Year
- PHVS N/A
- BHLB $31.27
- Revenue Next Year
- PHVS N/A
- BHLB $78.77
- P/E Ratio
- PHVS N/A
- BHLB $10.64
- Revenue Growth
- PHVS N/A
- BHLB 33.05
- 52 Week Low
- PHVS $11.51
- BHLB $22.27
- 52 Week High
- PHVS $25.76
- BHLB $32.36
- Technical
- Relative Strength Index (RSI)
- PHVS 73.31
- BHLB 58.05
- Support Level
- PHVS $17.63
- BHLB $26.28
- Resistance Level
- PHVS $19.00
- BHLB $26.96
- Average True Range (ATR)
- PHVS 1.20
- BHLB 0.59
- MACD
- PHVS 0.35
- BHLB 0.16
- Stochastic Oscillator
- PHVS 92.15
- BHLB 76.64
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About BHLB Berkshire Hills Bancorp Inc.
Berkshire Hills Bancorp Inc is a holding company. It provides Commercial Banking, Retail Banking, Consumer Lending, Private Banking and Wealth Management services.